Frontlight ResearchEarly access
CompletedNo phase
The Safety of Pharmacopuncture on Musculoskeletal Patients
Key facts
- Who runs it
- Jaseng Medical Foundation
- Where
- South Korea7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,000 people enrolled
- Started
- 27 Apr 2022
- Ended
- 3 Feb 2025
- Type of study
- Observational
- Treatments tested
- Pharmacopuncture
- Record updated
- 4 September 2025
Who can take part
- Age
- 19 years to 69 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Inpatients with diagnosed spinal joint disease
- Patients who received pharmacopuncture treatment during hospitalization
- Patients who are 19 years of age or older and less than 70 years old
- Patients who agreed to participate in the clinical study and voluntarily given written informed consent
Who cannot take part
- Patients with difficulty or refusal to give sign written informed consent
- Patients for whom the researchers judge participation in the clinical study to be difficult
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the safety of pharmacopuncture by observing any adverse events that may occur after pharmacopuncture treatment in with spinal joint disease hospitalized patients at 7 Korean medicine hospitals and analyzing blood test results.
Treatments tested
- Pharmacopuncture
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Safety Assessment of Pharmacopuncture on Musculoskeletal Patients: a Multi-center, Registry
- Record updated
- 4 September 2025